25 junho 2020
Comissão de Proteção de Dados diz que ainda não emitiu parecer sobre aplicação anti-Covid: A Comissão Nacional de Proteção de Dados prevê emitir parecer sobre a aplicação Stay Away “muito em breve”. Esta aplicação que vai ser disponibilizada gratuitamente alerta os seus utilizadores se estiveram em contacto com alguém sinalizado como estando infetado com Covid-19. INESC TEC garante que aplicação respeita a privacidade dos seus utilizadores e que é à prova de hackers.
China to run human coronavirus vaccine trial in UAE: China is seeking to trial potential vaccines overseas because of a lack of new patients at home.
Over a dozen experimental vaccines are being trialled around the world. None of them has yet successfully completed a late-stage “Phase 3” test to determine efficacy in shielding healthy people from the virus, which has killed over 470,000 people around the world.
Such trials involve thousands of participants and normally take place in countries where the virus is widespread, so that the vaccine can be observed in a real-life environment.
Over a dozen experimental vaccines are being trialled around the world. None of them has yet successfully completed a late-stage “Phase 3” test to determine efficacy in shielding healthy people from the virus, which has killed over 470,000 people around the world.
Such trials involve thousands of participants and normally take place in countries where the virus is widespread, so that the vaccine can be observed in a real-life environment.
Does Your Blood Type Affect Your Risk of Covid-19? An intriguing study published last week found a link between covid-19 severity and having type A blood; type O blood, on the other hand, was linked to a lower chance of severe illness. But it’s unlikely that any potential connection between covid-19 and blood type will be very relevant to the average person.The study, published in the New England Journal of Medicine, involved nearly 2,000 severely ill covid-19 patients in Spain and Italy. Researchers looked at these people’s genetic code, in what’s known as a genomewide association study, or GWAS. They compared their genetics to the genetics of a similar control group, looking for any differences that could plausibly influence someone’s risk of catching the infection or having a more serious case.
Subscrever:
Comentários (Atom)
-
The dangers of Covid-19 far outweigh the risks of a vaccine : So can I tell you that there won't be a long-term unknown side effect to t...
-
The Value of a Cure: An Asset Pricing Perspective : We provide an estimate of the value of a cure using the joint behavior of stock prices ...
-
A flood of coronavirus apps are tracking us. Now it’s time to keep track of them. So far we have documented 25 individual, significant auto...